Please login to the form below

Not currently logged in
Email:
Password:

BMS names Gerald Storch to board of directors

Chairman and CEO of Toys“R”Us brings retail experience to pharma company

 Gerald Storch - Bristol-Myers SquibbBristol-Myers Squibb (BMS) has appointed Toys“R”Us chairman and CEO Gerald Storch to its board of directors.

The US pharma firm said Storch will serve as a member of its audit committee as well as the compensation and management development committee of the board of directors.

Despite his lack of experience in the pharma industry, Storch has held a number of high level positions at a number of retail and business services companies.

Prior to joining Toys “R” Us in 2006, he was vice chairman at retailers Target Corporation. He has also been a partner at management consultancy McKinsey & Company.

“We are thrilled to have a person of Jerry's calibre, an industry leader with an excellent track record of success in branding and positioning a global franchise for growth, on our board of directors,” said Lamberto Andreotti, CEO at BMS.

James Cornelius, BMS' chairman, added: “Jerry's broad business and financial experience, focus on innovation and tremendous integrity make him an ideal member of our board of directors. I look forward to his contributions.”

27th January 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics